VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner

American Journal of Physiology - Cell Physiology

Volumn 307, Issue 1, 2014, Pages

  Alshafie, Walaa ^a   Chappe, Frederic G ^a   Li, Mansong ^a   Anini, Younes ^a   Chappe, Valerie M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cystic fibrosis associated ligand; Cystic fibrosis transmembrane conductance regulator; Ezrin radixin moesin; Protein kinase C epsilon; Vasoactive intestinal peptide

Indexed keywords

ACTIN BINDING PROTEIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN KINASE C EPSILON; PROTEIN NHERF 1; PROTEIN P ERM; SCAFFOLD PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; CARRIER PROTEIN; CFTR PROTEIN, HUMAN; CYTOSKELETON PROTEIN; EZRIN; GOPC PROTEIN, HUMAN; MEMBRANE PROTEIN; MOESIN; PHOSPHOPROTEIN; PRKCE PROTEIN, HUMAN; PROTEIN BINDING; RADIXIN; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR;

ACTIN FILAMENT; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; BRONCHUS; CELL LINE; CYTOLOGY; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; TIME;

BRONCHI; CARRIER PROTEINS; CELL LINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOSKELETAL PROTEINS; EPITHELIAL CELLS; HUMANS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-EPSILON; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TIME FACTORS; TRANSFECTION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84903555062     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00296.2013     Document Type: Article

References (58)

1. Alcolado N, Conrad DJ, Rafferty S, Chappe FG, Chappe VM. VIPdependent increase in F508del-CFTR membrane localization is mediated by PKCepsilon. Am J Physiol Cell Physiol 301: C53-C65, 2011.
2. Ameen N, Silvis M, Bradbury NA. Endocytic trafficking of CFTR in health and disease. J Cyst Fibros 6: 1-14, 2007.
3. Ameen NA, Marino C, Salas PJ. cAMP-dependent exocytosis and vesicle traffic regulate CFTR and fluid transport in rat jejunum in vivo. Am J Physiol Cell Physiol 284: C429-C438, 2003.
4. Bajnath RB, Groot JA, De Jonge HR, Kansen M, Bijman J. Synergistic activation of non-rectifying small-conductance chloride channels by forskolin and phorbol esters in cell attached patches of the human colon carcinoma cell line HT-29cl.19A. Pflügers Arch 425: 100-108, 1993.
5. Becq F, Hollande E, Gola M. Phosphorylation-regulated low-conductance Cl-channels in a human pancreatic duct cell line. Plugers Arch 425: 1-2, 1993.
6. Bradbury NA. Intracellular CFTR: localization and function. Physiol Rev 79: 175-191, 1999.
7. Bretscher A, Chambers D, Nguyen R, Reczek D. ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16: 113-143, 2000.
8. Cantiello HF. Role of the actin cytoskeleton in the regulation of the cystic fibrosis transmembrane conductance regulator. Exp Physiol 81: 505-514, 1996.
9. Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression. Am J Physiol Cell Physiol 290: C262-C270, 2006.
10. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 173: 1139-1144, 2006.
11. Chappe F, Loewen ME, Hanrahan JW, Chappe V. Vasoactive intestinal peptide increases cystic fibrosis transmembrane conductance regulator levels in the apical membrane of Calu-3 cells through a protein kinase C-dependent mechanism. J Pharmacol Exp Ther 327: 226-238, 2008.
12. Chappe V, Hinkson DA, Howell LD, Evagelidis A, Liao J, Chang XB, Riordan JR, Hanrahan JW. Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA 101: 390-395, 2004.
13. Chappe V, Hinkson DA, Zhu T, Chang XB, Riordan JR, Hanrahan JW. Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J Physiol 548: 39-52, 2003.
14. Chappe V, Said SI. VIP as a Corrector of CFTR Trafficking and Membrane Stability, Cystic Fibrosis-Renewed Hopes Through Research, edited by Sriramulu D. Rijeka, Croatia: InTech, 2012.
15. Cheng J, Wang H, Guggino WB. Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL. J Biol Chem 279: 1892-1898, 2004.
16. Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE, Cutting GR, Li M, Stanton BA, Guggino WB. A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 277: 3520-3529, 2002.
17. Cushing PR, Vouilleme L, Pellegrini M, Boisguerin P, Madden DR. A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR. Agnew Chem Int Ed Engl 49: 9907-9911, 2010.
18. Denning GM, Ostedgaard LS, Cheng SH, Smith AE, Welsh MJ. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J Clin Invest 89: 339-349, 1992.
19. Deora AA, Diaz F, Schreiner R, Rodriguez-Boulan E. Efficient electroporation of DNA and protein into confluent and differentiated epithelial cells in culture. Traffic 8: 1304-1312, 2007.
20. Favia M, Guerra L, Fanelli T, Cardone RA, Monterisi S, Di Sole F, Castellani S, Chen M, Seidler U, Reshkin SJ, Conese M, Casavola V. Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o-cells. Mol Biol Cell 21: 73-86, 2010.
21. Gadsby DC, Nairn AC. Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev 79: S77-S107, 1999.
22. Gadsby DC, Nairn AC. Regulation of CFTR Cl-ion channels by phosphorylation and dephosphorylation. Adv Second Messenger Phosphoprotein Res 33: 79-106, 1999.
23. Gadsby DC, Vergani P, Csanady L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440: 477-483, 2006.
24. Guerra L, Fanelli T, Favia M, Riccardi SM, Busco G, Cardone RA, Carrabino S, Weinman EJ, Reshkin SJ, Conese M, Casavola V. Na+/H+ exchanger regulatory factor isoform 1 overexpression modulates cystic fibrosis transmembrane conductance regulator (CFTR) expression and activity in human airway 16HBE14o-cells and rescues DeltaF508 CFTR functional expression in cystic fibrosis cells. J Biol Chem 280: 40925-40933, 2005.
25. Guggino WB, Stanton BA. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 7: 426-436, 2006.
26. Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N, Welsh MJ, Lefkowitz RJ. A C-terminal motif found in the b2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na1yH1 exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci USA 95: 8496-8501, 1998.
27. Hayashi K, Yonemura S, Matsui T, Tsukita S. Immunofluorescence detection of ezrin/radixin/moesin (ERM) proteins with their carboxylterminal threonine phosphorylated in cultured cells and tissues. J Cell Sci 112: 1149-1158, 1999.
28. Hong SH, Osborne T, Ren L, Briggs J, Mazcko C, Burkett SS, Khanna C. Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells. Vet Comp Oncol 9: 207-218, 2011.
29. Hu W, Howard M, Lukacs GL. Multiple endocytic signals in the C-terminal tail of the cystic fibrosis transmembrane conductance regulator. Biochem J 354: 561-572, 2001.
30. Kwon S, Pollard H, Guggino WB. Knockdown of NHERF1 enhances degradation of temperature rescued ΔF508 CFTR from the cell surface of human airway cells. Cell Physiol Biochem 20: 763-772, 2007.
31. Laburthe M, Couvineau A, Tan V. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. Class II G proteincoupled receptors for VIP and PACAP: Structure, models of activation and pharmacology. Peptides 28: 1631-1639, 2007.
32. Ladias JAA. Structural insights into the CFTR-NHERF interaction. J Membr Biol 192: 79-88, 2003.
33. Lehrich RW, Aller SG, Webster P, Marino CR, Forrest JN Jr. Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium. J Clin Invest 101: 737-745, 1998.
34. Li J, Callaway DJE, Bu Z. Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1. J Mol Biol 392: 166-180, 2009.
35. Li J, Dai Z, Jana D, Callaway DJ, Bu Z. Ezrin controls the macromolecular complexes formed between an adapter protein Na+/H+ exchanger regulatory factor and the cystic fibrosis transmembrane conductance regulator. J Biol Chem 280: 37634-37643, 2005.
36. Li J, Poulikakos PI, Dai Z, Testa JR, Callaway DJ, Bu Z. Protein kinase C phosphorylation disrupts Na+/H+ exchanger regulatory factor 1 autoinhibition and promotes cystic fibrosis transmembrane conductance regulator macromolecular assembly. J Biol Chem 282: 27086-27099, 2007.
37. Liedtke CM, Wang X. The N-terminus of the WD5 repeat of human RACK1 binds to airway epithelial NHERF1. Biochemistry (NY) 45: 10270-10277, 2006.
38. Liedtke CM, Raghuram V, Yun CC, Wang X. Role of a PDZ1 domain of NHERF1 in the binding of airway epithelial RACK1 to NHERF1. Am J Physiol Cell Physiol 286: C1037-C1088, 2004.
39. Liedtke CM, Yun CH, Kyle N, Wang D. Protein kinase C epsilondependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor. J Biol Chem 277: 22925-22933, 2002.
40. Lopez JP, Turner JR, Philipson LH. Glucose-induced ERM protein activation and translocation regulates insulin secretion. Am J Physiol Endocrinol Metab 299: E772-E785, 2010.
41. Louvet-Vallée S. ERM proteins: from cellular architecture to cell signaling. Biol Cell 92: 305-316, 2000.
42. Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, Grinstein S. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem 268: 21592-21598, 1993.
43. Lukacs GL, Segal G, Kartner N, Grinstein S, Zhang F. Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J 328: 353-361, 1997.
44. Monterisi S, Favia M, Guerra L, Cardone RA, Reshkin SJ, Casavola V, Marzulli D, Zaccolo M. CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity. J Cell Sci 125: 1106-1117, 2012.
45. Okiyoneda T, Lukacs GL. Cell surface dynamics of CFTR: the ins and outs. Biochim Biophys Acta 1773: 476-479, 2007.
46. Rafferty S, Alcolado N, Norez C, Chappe F, Pelzer S, Becq F, Chappe V. Rescue of functional F508del cystic fibrosis transmembrane conductance regulator by vasoactive intestinal peptide in the human nasal epithelial cell line JME/CF15. J Pharmacol Exp Ther 331: 2-13, 2009.
47. Reczek D, Berryman M, Bretscher A. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139: 169-179, 1997.
48. Reczek D, Bretscher A. The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J Biol Chem 273: 18452-18458, 1998.
49. Said SI, Chappe V, Hamidi SA. VIP. In: Handbook of Biologically Active Peptides, 2nd edition, edited by Kastin AJ. New York: Elsevier, 2012, p. 1535-1548.
50. Setiadi H, Sedgewick G, Erlandsen SL, McEver RP. Interactions of the cytoplasmic domain of P-selectin with clathrin-coated pits enhance leukocyte adhesion under flow. J Cell Biol 142: 859-871, 1998.
51. Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J Biol Chem 273: 19797-19801, 1998.
52. Simons PC, Pietromonaco SF, Reczek D, Bretscher A, Elias L. C-terminal threonine phosphorylation activates ERM proteins to link the cell's cortical lipid bilayer to the cytoskeleton. Biochem Biophys Res Commun 253: 561-565, 1998.
53. Swiatecka-Urban A, Brown A, Moreau-Marquis S, Renuka J, Coutermarsh B, Barnaby R, Karlson KH, Flotte TR, Fukuda M, Langford GM, Stanton BA. The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator(CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells. J Biol Chem 280: 36762-36772, 2005.
54. Thiagarajah JR, Verkman AS. CFTR pharmacology and its role in intestinal fluid secretion. Curr Opin Pharmacol 3: 594-599, 2003.
55. Turcios NL. Cystic fibrosis: an overview. J Clin Gastroenterol 39: 307-317, 2005.
56. Wang S, Raab RW, Schatz PJ, Guggino WB, Li M. Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett 427: 103-108, 1998.
57. Wine JJ, Joo NS. Submucosal glands and airway defense. Proc Am Thorac Soc 1: 47-53, 2004.
58. Wolde M, Fellows A, Cheng J, Kivenson A, Coutermarsh B, Talebian L, Karlson K, Piserchio A, Mierke DF, Stanton BA, Guggino WB, Madden DR. Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. J Biol Chem 282: 8099-8109, 2007.